Mexican expert committee recommends granting approval to Bharat Biotech's Covaxin

The panel's report will now be sent to the federal medical safety commission's approval board, which usually follows such recommendations

The Associated Press March 06, 2021 10:38:15 IST

An illustration of COVAXIN, the vaccine candidate for COVID-19 developed by Bharat Biotech. Image: Bharat Biotech

Mexico City: A technical committee of experts in Mexico gave a unanimous favorable opinion Friday on approving the Covaxin vaccine made by the Indian pharmaceutical company Bharat Biotech.

The report by the committee for new molecules will be sent to the federal medical safety commission's approval board, which usually follows such recommendations.

The interim results from the vaccine manufacturer's late stage trials shows its COVID-19 vaccine to be about 81 percent effective in preventing illness from the coronavirus.

The Bharat Biotech vaccine was controversially approved by India in January without waiting for trials to confirm that the vaccine was effective. Since then 1.3 million of doses have been administered in India.

Health care workers have been reticent to take the shots and health experts are concerned the regulatory shortcut has amplified vaccine hesitancy. Bharat Biotech has already signed an agreement with Brazil to supply 20 million doses of the vaccine by September.

It will be the fifth vaccine approved for use in Mexico, which has received relatively small amounts of each. Mexico has administered only about 2.7 million doses of all vaccines, a tiny amount given the country''s population of 126 million.

Mexico reported 712 more confirmed deaths Friday, bringing the total to almost 190,000. However, Mexico does so little testing that government excess-death figures suggest the real toll was well above 220,000 at the start of January, the last date for which such figures are available. There were almost 6,800 more confirmed cases Friday, bringing the total to over 2.1 million.

Updated Date: March 06, 2021 10:38:15 IST

Most Read

Most Read

also read


India to soon get its first mRNA COVID-19 vaccine: Why is this being touted as a gamechanger?

Pune-based Gennova Biopharmaceuticals COVID-19 vaccine, which is awaiting a nod from India’s drug regulators, can be stored at temperatures between 2 and 8 degree Celsius, making its availability in remote areas possible too


As COVID-19 cases rise, vaccines play vital role to prevent mass hospitalization, adverse outcomes

Vaccines play a crucial role in preventing infection, hospitalizations, and adverse outcomes which cause deaths


Vaxxed to the max: A look at India's COVID vaccination drive that is set to overtake US, Europe and Canada combined

As per official data, a total of 1,96,24,21,213 doses have been administered so far across the country, which is set to cross the combined doses of the United States, Europe and Canada